Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Activists Call for Earlier Access to Hep C Treatments

Editor's pick
AIDSMeds
17 June 2011
Hepatitis C symptoms & diagnosis

Copy of Noninvasive Tests Reduce Need for Liver Biopsies in Hep C

Editor's pick
Kaiser Daily Global Health Policy Report
10 June 2011
Hepatitis C symptoms & diagnosis

Noninvasive Tests Reduce Need for Liver Biopsies in Hep C

Editor's pick
AIDSMeds
10 June 2011
Hepatitis C treatment

HIV-positive patients who receive therapy for acute HCV can be cured with just 24 weeks of therapy

News
6 June 2011
New & experimental hepatitis C treatment

Why Incivek and Victrelis Herald a New Era in Hepatitis C Treatment

Editor's pick
The Body
3 June 2011
Hepatitis A

HIV-positive patients have good long-term responses to hepatitis A vaccination

News
3 June 2011
New & experimental hepatitis C treatment

High Demand for New HCV Drugs Could Cause Ethical Problems

Editor's pick
Medscape
31 May 2011
Hepatitis C transmission & prevention

Abortion clinic doctor charged with infecting patients with hepatitis C

Editor's pick
The Guardian
27 May 2011
New & experimental hepatitis C treatment

NICE to appraise hep C drugs Victrelis and telaprevir

Editor's pick
InPharm
26 May 2011
New & experimental hepatitis C treatment

Achillion Announces Initiation of Phase 1 Trial of ACH-2684 for the Treatment of Hepatitis C

Editor's pick
Achillion
26 May 2011
Organ transplants

Allowing people with HIV to be organ donors could save lives of HIV-positive patients with kidney or liver failure

Editor's pick
Science Daily
25 May 2011
Hepatitis C treatment

The Fair Pricing Coalition Expresses Disappointment at the Price of Vertex’s Newly Approved Hepatitis C Drug

Editor's pick
Fair Pricing Coalition
25 May 2011
Liver disease

Gene associated with increased risk of cirrhosis for HIV/HCV-co-infected patients

News
24 May 2011
Harm reduction

Injecting Advice: Avoid Hep C, Avoid Track Marks

Editor's pick
Injecting Advice
24 May 2011
New & experimental hepatitis C treatment

US approval for hepatitis C drug telaprevir

News
23 May 2011
New & experimental hepatitis C treatment

European approval recommended for hepatitis C drug boceprevir

News
23 May 2011
New & experimental hepatitis C treatment

European approval for new hepatitis C drug boceprevir (Victrelis)

Editor's pick
European Medicines Agency
20 May 2011
New & experimental hepatitis C treatment

The Fair Pricing Coalition Expresses Dismay at the Price of Merck's Newly Approved Hepatitis C Drug

Editor's pick
Thebody.com
18 May 2011
New & experimental hepatitis C treatment

Merck, Roche to Work Together on Hepatitis C Treatments

Editor's pick
San Francisco Chronicle
18 May 2011
New & experimental hepatitis C treatment

Getting Ready; Telaprevir or Boceprevir ?

Editor's pick
HCV New Drugs Research
18 May 2011
New & experimental hepatitis C treatment

Merck’s Hepatitis C Drug Wins F.D.A. Approval

Editor's pick
New York Times
16 May 2011
Hepatitis C symptoms & diagnosis

Age-Based Hep C Screening May Work Better Than Risk-Based Screening

Editor's pick
Internal Medicine News
9 May 2011
Hepatitis C treatment

Genetic variation associated with response to hepatitis C therapy in HIV co-infected patients

News
5 May 2011
Hepatitis C treatment

HIV treatment preserves CD4 cell count during and after HCV therapy in co-infected patients

News
3 May 2011